Donoghue Forlines LLC Takes $2.76 Million Position in Synopsys, Inc. $SNPS

Donoghue Forlines LLC acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,594 shares of the semiconductor company’s stock, valued at approximately $2,760,000. Synopsys accounts for approximately 0.8% of Donoghue Forlines LLC’s holdings, making the stock its 14th biggest holding.

Other hedge funds also recently bought and sold shares of the company. Stanley Laman Group Ltd. raised its stake in Synopsys by 542.9% in the third quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after buying an additional 10,874 shares during the last quarter. Symphony Financial Ltd. Co. increased its holdings in shares of Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in Synopsys by 1.7% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock worth $91,660,000 after purchasing an additional 2,991 shares in the last quarter. Finally, Waverton Investment Management Ltd grew its position in Synopsys by 15.0% during the 2nd quarter. Waverton Investment Management Ltd now owns 578,299 shares of the semiconductor company’s stock worth $296,630,000 after purchasing an additional 75,374 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on SNPS shares. Citigroup began coverage on shares of Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price target for the company. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $605.00 to $560.00 in a research note on Tuesday, December 9th. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Morgan Stanley increased their price objective on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Finally, Piper Sandler downgraded Synopsys from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $602.00 to $520.00 in a report on Tuesday. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $553.57.

View Our Latest Stock Analysis on SNPS

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 4,157 shares of company stock worth $1,945,036 in the last three months. 0.62% of the stock is owned by corporate insiders.

Synopsys Trading Up 1.6%

SNPS stock opened at $516.31 on Friday. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The firm has a market cap of $98.78 billion, a P/E ratio of 64.62, a PEG ratio of 4.30 and a beta of 1.12. The company’s 50-day simple moving average is $455.35 and its 200-day simple moving average is $504.95.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the prior year, the firm posted $3.40 EPS. Synopsys’s quarterly revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.